Navigating the Legal Landscape of Pharmaceutical Recalls

This article examines the key legal challenges involved in pharmaceutical recalls, including antitrust compliance, FDA requirements, liability management, and data privacy. It underscores the importance of proactive legal strategies to ensure regulatory adherence, protect public trust, and reduce legal risks throughout the recall process.

• Read more about Navigating the Legal Landscape of Pharmaceutical Recalls

Retail Media Readiness Checklist

The Retail Media Network (RMN) landscape is evolving rapidly, and so are the challenges that come with it. As RMNs grow toward a new level of utility and connectivity, many marketers are left juggling fragmented strategies, limited measurement, and pressure to prove performance in a challenging economy. To compete in 2025 and beyond, marketers need RMN strategies that are built to drive commerce. Whether you're building a network, buying across them, or navigating both sides of the marketplace, this is your guide to future-proofing your RMN approach.

• Read more about Retail Media Readiness Checklist

2025 Back-to-School Predictions Report

This Back-to-School (BTS) season, families are more focused than ever on squeezing their wallets, protecting their health, and making smart, intentional purchases. They're weighing every decision — focusing on not only price, but also emotional and practical value. That gives brands and retailers a powerful window to connect — and win their share of Back-to-School spending. Here is Your Checklist for Smarter BTS Marketing Our latest report breaks down the key trends, shopper behaviors, and strategies you need to know now: 

• Read more about 2025 Back-to-School Predictions Report

Why Effective Recall Management is Critical to Patient Safety

Effective recall management is essential in pharma to protect patients, meet regulations, and maintain trust. It must be proactive, fast, and clearly communicated.

• Read more about Why Effective Recall Management is Critical to Patient Safety

The Tariff Effect: How Alcohol Brands Can Turn Tariff Challenges into Opportunities

This blog is part of our ongoing series exploring how tariffs, inflation, and shifting economic forces are reshaping shopper behavior and business strategy in the grocery industry. If you missed the first post, “Navigating Tariffs, Inflation, and Uncertainty for CPGs and Retailers,” you can catch up here.

• Read more about The Tariff Effect: How Alcohol Brands Can Turn Tariff Challenges into Opportunities

The Tariff Effect: Turning Price Sensitivity Into Purchase Intent

This blog is part of our ongoing series exploring how tariffs, inflation, and shifting economic forces are reshaping shopper behavior and business strategy in the grocery industry. If you missed the first post, “Navigating Tariffs, Inflation, and Uncertainty for CPGs and Retailers,” you can catch up here.

• Read more about The Tariff Effect: Turning Price Sensitivity Into Purchase Intent

The Future of Shopper-Centric Retail Media

Grocery shopping has always been a deeply personal experience. It’s how we feed and nourish ourselves and our loved ones. And while the human-to-human connection will always play a role, shoppers today expect convenience, relevance, and value whether they are browsing grocery aisles or preparing their list from their couch. That’s where we see in-store retail media shine.

• Read more about The Future of Shopper-Centric Retail Media

A Legacy of Innovation and Future of Limitless Possibilities

As Inmar Intelligence celebrates 45 years, we reflect on a legacy of innovation and a future of limitless possibilities. Since day one, we’ve empowered industries with cutting-edge, data-driven solutions that fuel sustainable growth, and enhance consumer experiences.

• Read more about A Legacy of Innovation and Future of Limitless Possibilities

Reframing Surplus: A Strategic Asset in Pharma Supply Chains

In pharma, surplus inventory is not waste—it's a strategic asset. By aligning inventory management with sustainable reverse logistics, companies can reduce risk, maintain continuity, and enhance ESG performance while supporting innovation and patient access.

• Read more about Reframing Surplus: A Strategic Asset in Pharma Supply Chains